1.
Cell Rep Med
; 4(11): 101293, 2023 11 21.
Article
in English
| MEDLINE
| ID: mdl-37992680
ABSTRACT
In this issue, Pang and colleagues1 identify the protease legumain as a potential immunotherapy target in glioblastoma that drives tumor-associated macrophages in response to hypoxia.
